On Friday, while Rick Bright was in the process of filing what promises to be a damning whistleblower complaint to the Inspector General of the Department of Health and Human Services, President Donald Trump announced that he was firing the inspector general, Christi Grimm, and nominating a handpicked replacement.
Grimm became inspector general in January and came under attack from Trump after her office published a report pointing out severe shortages of testing supplies and personal protective equipment.
In a tweet, Trump called the report, which was based on interviews with hospital administrators from 323 hospitals in 46 states, the District of Columbia, and Puerto Rico, “another Fake Dossier” because Grimm had worked for the Obama administration.
The highly anticipated whistleblower report from Bright is expected to focus on hydroxychloroquine, a drug that Trump hyped as a “game changer.”.
On Friday, Trump met with Gilead CEO Dan O’Day to announce that the Food and Drug Administration would be giving the drug emergency use authorization as a treatment for Covid-19.
“We’re going to be having some really incredible results,” Trump predicted.
In the Chinese study, 12 percent of patients who were taking remdesivir had to stop because of adverse reactions to the drug, some of which were life-threatening. »